Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new t... Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. Its goal is to develop and commercialize new treatment options for age-related inflammatory conditions, with hemochromatosis as its initial clinical focus, and to thereafter expand the development of TELOMIR-1 to post-chemotherapy recovery as well as a broader range of other age-related inflammatory diseases and conditions such as osteoarthritis. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.32 | 7.47663551402 | 4.28 | 5.17 | 4.05 | 132611 | 4.45303247 | CS |
4 | 0.06 | 1.32158590308 | 4.54 | 5.34 | 4.01 | 236175 | 4.79158224 | CS |
12 | 0.37 | 8.74704491726 | 4.23 | 7.0791 | 3.198 | 190883 | 4.81369904 | CS |
26 | 0.23 | 5.26315789474 | 4.37 | 8.4 | 3.11 | 151381 | 5.35027614 | CS |
52 | -2.4 | -34.2857142857 | 7 | 20.72 | 3.11 | 105952 | 5.79865891 | CS |
156 | -2.4 | -34.2857142857 | 7 | 20.72 | 3.11 | 105952 | 5.79865891 | CS |
260 | -2.4 | -34.2857142857 | 7 | 20.72 | 3.11 | 105952 | 5.79865891 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관